Dr. Mikhail Blagosklonny Distinguished Physician and Scientist Joins Roswell Park Cancer Institute

Mikhail Blagosklonny is a professor of oncology at New York’s Roswell Park Cancer Institute. In his field, he studies cancer and aging. He received his M.D in internal medicine and his Ph.D in cardiology and experimental medicine from the First Pavlov State Medical University of St.Petersburg.

In 2002 he was appointed an associate professor of medicine at the New York Medical College in Valhalla, New York. He then took a position at Ordway Research Institute in Albany, New York as a senior scientist where he stayed until 2009, at which time he was appointed professor of oncology at Roswell Park Cancer Institute in Buffalo, New York.

According to Impact Journals, Mikhail Blagosklonny’s interest lie in cancer and cancer therapies that protect normal cells from damage. The aging process is also one of his interests in which he researches underlying mechanisms of aging and the anti-aging drugs.

Mikhail Blagosklonny has authored over 170 research articles and reviews and is the Founding Editor and Editor-in-Chief of Cell Cycle and Associate Editor of Cancer Biology & Therapy. International Journal of Cancer, Cell Death & Differentiation, American Journal of Pathology, and PLOS ONE as also among his editorial interests.

In regards to his research interests, these vary from clinical investigations, molecular and cellular biology. This also includes signal transduction of basic science into the new anticancer strategies. He has extended this into the pathways from cancer to aging, to reveal the potential targets for slowing down aging and age-related diseases.

His hypothesis of the role of TOR signaling in aging and cancer is in proposing a popular cancer drug, rapamycin, as a possible treatment for life extension. He is a passionate advocate for the rapamycin drug in the search for longevity.

According to the scientists of Roswell Park Cancer Center Dr. Mikhail Blagosklonny will ease the development of the methods of cancer therapy and prevention and the new anti-cancer strategies.

Research Gate revealed to us that Mikhail Blagosklonny shares his approaches and ideas in regards to protection of normal cells for the radiology and chemotherapy,and the specific tissue therapy and anti-tissue therapy of cancer. The selective combinations of anticancer drugs and the prevention of cancer by means of slowing down organismal aging are also among his research.

Donald Scott NYC tools for shaving

A straight razor is made up of a blade, and a pair of handles called scales. The blade and the handle are held together using a pin. The blade can fold into its handle. The blade shank is the one held during shaving. During shaving, the thumb holds the underside of the blade shank. The other fingers hold the topside of the shank. The handle is placed between the ring finger and the little finger. The skin must tightly stretch when shaving. For safety, the blade is set at an angle of 30 degrees to the skin. Donald Scott NYC is one of the many manufacturers of razor tools and is rated as the best in the market.
A single straight razor can be used multiple times without replacing hence reducing the cost of shaving. A shavette razor is a similar product used for shaving. It uses changeable blades and is efficient for shaving when in a hurry. It also requires less maintenance.
Donald Scott NYC most popular products include New Naked Blades which are disposable razors with maximum flexibility and glide. Also, Donald Scott NYC offers a Groom Stik Pro; a long lasting battery operated trimmer that grooms hard to reach places like near the ears and eyebrows.

Timothy Armour: Chairman And Chief Executive Officer

Timothy Armour is the Chairman and Chief Executive Officer of Capital Group. He has completed a bachelors degree in economics at Middlebury College, and has completed over thirty years of investment experience all within Capital Group. Capital Group is an American financial services company and one of the world’s leading and largest investment management firms.

Armour was elected to become the Chairman of Capital Group, after serving as Chairman of Capital Group’s management committee and Capital Research and Management Company. The change of leadership seems to have been years in the making, and was finally complete after the passing of Jim Rothenberg, the former Chairman.

Capital Group and Samsung Asset Management announced plans for a partnership, that would work on developing investment plans for investors in Korea. The strategic partner ship would focus on four main components: investment management processes, retirement solutions, product management and distribution channel support.

According to the agreement, Capital Group would help Samsung Asset Management become more knowledgeable when it comes to ‘Capital Style Active Management.’ And would help the Samsung become more proficient at business management and client management. This agreement was partly made in hopes that Samsung Asset Management would become one of Asia’s top home grown management companies by the year of 2020.

Another key motivator for the partnership was in order to develop co branded retirement products for the Korean market. The Samsung CEO Sung-Hoon Koo has said that they have been expecting demands for retirement solutions to increase, so the strategic partnership with Capital Group was welcomed. This demand for retirement solutions will benefit both Samsung and Capital Group, with more business and support.

And finally, another reason the partnership was formed was so the Capital Group’s products and services were to be used and distributed across multiple Samsung distribution channels. The partnership was to the core a strategic investment for both companies with Samsung Asset Management to learn valuable information from the more experienced Capital Group, and the Capital Group to use Samsung distribution channels to distribute some of their own products and services to the Korean investors. Armour had this to say about the matter, “broader plan is to co-design investment solutions to fulfill the savings, retirement and insurance-linked needs of Korean investors.”